Abstract
. NO is a signalling molecule associated with improved cardiovascular and skeletal muscle functions that may potentially enhance physical performance and even facilitate adaptations to exercise training (4) . Nevertheless, the scientific literature provides controversial results regarding the performance-enhancing effects induced by NO 3 − supplementation.
Two systematic reviews and meta-analyses on this topic have recently been published, establishing clear practical recommendations and directions for future studies investigating changes in performance induced by NO 3 − supplementation (5, 6) . Hoon et al. (5) and McMahon et al. (6) analysed data according to the exercise protocol used (i.e. time trials, open-ended tests and graded-exercise tests) and observed that dietary NO 3 − supplementation improved endurance only when performance was evaluated using open-ended tests. Notably, none of these two meta-analyses divided and analysed separately the studies conducted with athletes or non-athletes, as we are proposing here. McMahon et al. performed a continuous variable metaregression analysis and reported that the fitness level did not have an influence on the ergogenic effect of dietary NO 3 − supplementation (6) . However, grouping the data according to the exercise protocol may result in an important bias. In fact, the studies using open-ended tests were mainly performed in non-athletes. In contrast, most studies using time trials were performed in athletes. This disparity might have led to a misinterpretation of the results owing to an unintentional division based on individuals' physical fitness level. Interestingly, neither of the two recent systematic reviews addressed the following question raised by Jonvik et al.: 'Can elite athletes benefit from dietary nitrate supplementation?' (7) (8) (9) . Therefore, information regarding the effectiveness of NO 3 − supplementation in individuals with different physical fitness levels is lacking. Moreover, physical performance is modulated by various mechanisms and depends on several factors, including the duration of the test performed (i.e. short or long duration). Thus, the influence of the test duration on the changes in performance induced by NO 3 − supplementation in individuals with different fitness levels remains to be investigated. Increased NO availability resulting from NO 3 − supplementation has beneficial effects on health and physical performance and has been largely studied in humans and laboratory animals. In the central nervous system, NO prevented exaggerated increases in the core body temperature in rats subjected to exercise by increasing cutaneous heat loss and decreasing the metabolic cost of running (10) (11) (12) (13) . In these rat studies, the pharmacological blockade of central NO synthesis markedly impaired endurance (10, 12) , whereas an increased NO availability in the brain did not affect endurance (13) . In humans, the physical performance benefits mediated by dietary NO 3 − supplementation have been attributed to peripheral effects, including reduced arterial pressure and VO 2 . The latter effect leads to a reduced oxygen cost during exercise that is most likely due to the reduced cost of ATP for muscle force production, improved mitochondrial efficiency and increased muscle oxygenation (14, 15) . In contrast, the adverse events related to NO 3 − supplementation are minor and restricted to red urine (beeturia) and stool, which usually results from the ingestion of beetroot in juice or meals (16, 17) . Interestingly, both acute and chronic supplementations of NO 3 − have been shown to either improve (18) (19) (20) (21) (22) (23) (24) or have no effect (14, (25) (26) (27) (28) (29) on endurance performance. The uncertain efficacy of NO 3 − supplementation appears to be related to the fitness level of the investigated population as demonstrated by a careful evaluation of the cumulative number of trials reporting the performance benefits or lack thereof in both non-athletes (healthy individuals engaged in regular physical activity but not involved in sports competitions) and athletes ( Fig. 1) . Notably, nearly 65 % of the publications on this topic did not report the benefits resulting from NO 3 − supplementation. However, if only those studies performed in non-athletes are considered, approximately 45 % of the publications show a supplementation-mediated positive effect on physical performance, whereas the percentage of papers showing beneficial effects in athletes is lower than 30 % (Fig. 1) . Collectively, these observations reinforce the relevance of the present systematic review and meta-analysis, which help clarify the contradictory reports of the effects of NO 3 − supplementation on physical performance.
Therefore, the present study systematically analysed whether different physical fitness levels (i.e. non-athletes v. athletes) influence the effects of NO 3 − supplementation on physical performance. In addition, we also evaluated the influence of the duration of the tests used to measure performance (i.e. short v. long duration) and the test protocol used (i.e. time trials v. openended tests v. graded-exercise tests) on the effect of NO 3 − supplementation on physical performance in individuals with different physical fitness levels. Thus, the present analyses provide information that is useful to exercise practitioners, athletes, coaches and conditioning professionals who are interested in improving physical performance and achieving health benefits.
Methods

Search strategy
This systematic review and meta-analysis was conducted and reported according to the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement (30, 31) . A systematic search of electronic databases, including PubMed, Web of Science, SPORTDiscus and ProQuest, was performed in August 2017 without any date restrictions. The search strategy was supplemented by manual cross-matching of each publication reference list and key author searches. Combinations of the following keywords were used: effort, endurance, exercise, fatigue, nitrate, nitrate supplementation, nitrite, nitrite supplementation, performance, power, running, speed, sport and workload.
Study selection
Studies that met the following criteria were included in this systematic review and meta-analysis: (i) the participants were healthy humans (either non-athletes or athletes), (ii) physical performance was measured after the participants were supplemented with NO 3 − and (iii) the studies were placebocontrolled trials. Furthermore, all included studies were written in English. Reviews, summaries, case studies and letters were not included, although this bibliography was consulted. Studies involving hypoxic conditions, individuals with diseases, exercise in the heat, children and elderly people, and laboratory animals were excluded. On the basis of the search and inclusion/exclusion criteria, fifty-four studies (106 trials) were selected for inclusion in this systematic review, and fifty-three studies (104 trials) were included in the meta-analysis (Fig. 2) . Notably, several studies measured more than one physical performance parameter. The data addressing the effect of NO 3 − supplementation on each parameter were included, and therefore the number of trials was greater than the number of studies. Only one study with one trial (20) and one trial in a study with several trials (32) were excluded from the meta-analysis because they did not include the standard deviation data needed to calculate the effect size.
Data grouping
The selected studies were divided into the following two groups according to the physical fitness level of the individuals tested: non-athletes (forty-three trials) and athletes (sixty-three trials). The individuals were allocated into these two groups according to the classification used by the authors of the research papers, which were consulted. This strategy was efficient in dividing the participants into two groups with different functional capacities as demonstrated by the higher VO 2max values in the athletes than in the non-athletes (61·1 (SD 1·8) v. 50·5 (SD 1·8) ml/kg per min; t-test, P < 0·05). Similarly, the studies selected for inclusion in the meta-analysis were initially divided into the following two groups: non-athletes (forty-three trials) and athletes (sixty-one trials). The two groups were then subdivided according to the duration of the test performed as follows: short duration (non-athletes, eighteen trials; athletes, seventeen trials) or long duration (non-athletes, twenty-five trials; athletes, forty-four trials). Exercises lasting less than 180 s, thereby characterised by a relevant anaerobic contribution to the energy expenditure, were considered short-duration exercises. Alternatively, exercise bouts lasting more than 180 s were considered longduration exercises (33) . In addition, because NO 3 − supplementation has been shown to have a positive effect on physical performance only in non-athletes during long-duration tests, this group was further subdivided according to the test protocol used (openended tests (constant power), fourteen trials; time trials, four trials; and graded-exercise tests (incremental power), five trials). Open-ended tests consist of exercising at a constant power until the participant is volitionally fatigued; the time until fatigue, which may be highly variable among subjects, is considered the main measure of performance in this test. Finally, owing to the large number of studies in cycling athletes, a specific analysis was conducted for this sport (thirty-seven trials).
Analysis of the relationship between the performance level and the response to NO 3 − supplementation
Because the authors of the research papers may have been imprecise in the classification of their subjects as athletes, we decided to perform an objective analysis. Thus, the individuals were grouped into different performance levels (PL) according to the classification provided by De Pauw et al. (34) . These authors divided the participants in sport science studies into the following five different levels: performance level 1 (PL1) included untrained and sedentary subjects with a VO 2max < 45·0 ml/kg per min; performance level 2 (PL2) included recreationally trained subjects with a VO 2max between 45·0 and 54·9 ml/kg per min; performance level 3 (PL3) included trained subjects with a VO 2max between 55·0 and 64·9 ml/kg per min; performance level 4 (PL4) included highly trained subjects with a VO 2max between 65·0 and 71·0 ml/kg per min; and performance level 5 (PL5) included professional subjects with a VO 2max > 71·0 ml/kg per min. On the basis of this study, we grouped the individuals into five levels and then evaluated the relationship between the PL and the changes in performance induced by NO 3 − supplementation.
Risk of bias assessment
Two independent reviewers assessed the risk of bias using an adapted Grading of Recommendations Assessment, Development and Evaluation (GRADE) instrument (35) . Discrepant evaluations were settled via discussion with a third reviewer. Using this approach, it was possible to evaluate the risk of bias in each study included in the present systematic review. Domains reflecting sequence generation, allocation concealment, blinding of participants and personnel, incomplete outcome data, selective outcome reporting and other sources of bias were evaluated.
Statistical analysis
The mean and standard deviation values of the performance indexes in both the NO 3 − supplementation and control trials were obtained from the data provided in the consulted research papers. Heterogeneity was evaluated using the χ 2 test for homogeneity and the I 2 statistic. The effect size (Cohen's d or Hedges' g) was calculated for the performance indexes in each study. Then, a weighted-mean estimate of the effect size was calculated to account for differences in the sample sizes. The mean unweighted effect size and associated 95 % CI were also calculated. We used Cohen's classification of the effect size magnitude, where d < 0·20 for negligible effect; d = 0·20-0·49 for small effect; d = 0·50-0·79 for moderate effect; and d > 0·8 for large effect (36) . The χ 2 test was used to compare the frequency of trials showing improved performance in response to NO 3 − supplementation among the different PL. Student's t test was used to compare the VO 2max between the non-athletes and athletes. Pearson's correlations were performed to evaluate the association between the supplementation parameters (dose, number of days and total amount ingested) and the changes in physical performance. Publication bias was assessed by a visual inspection of funnel plots of the standard error v. effect size (37) .
Results
Systematic review
In total, 4732 studies were identified through the database and reference searches. After removing the duplicates and excluding papers that did not meet the eligibility criteria according to a review of their titles, abstracts and full texts, fiftyfour studies (106 trials and 662 individuals) were selected for inclusion in the systematic review (Fig. 2) . The characteristics of the subjects, including information regarding the supplementation regimens and effects of NO 3 − supplementation on the physical performance of non-athletes and athletes in each study, are summarised in Tables 1 and 2 , respectively. Notably, most studies used beetroot juice as a form of NO 3 − supplementation. However, these studies were heterogeneous in several supplementation features, including the ingested volume (70, 140, 250, 280 or 500 ml), dose (between 4·0 and 19·5 mmol), days of supplementation (between 1 and 15 d), timing of supplementation before the trial (between 40 and 1440 min) and the parameter measured to determine physical performance.
Meta-analyses
In total, fifty-three studies (104 trials and 648 individuals) were included in the meta-analysis.
Non-athletes. After pooling the data from forty-three trials, the mean effect size was 0·25 (95 % CI 0·11, 0·38), which indicates that the dietary NO 3 − supplementation had a small and significant beneficial effect on physical performance (P < 0·05; Fig. 3 ). According to a fixed-effects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 15·26, df = 42, P = 1·00).
Athletes. After pooling the data from sixty-one trials, the mean effect size was 0·04 (95 % CI −0·05, 0·15), which indicates that the dietary NO 3 − supplementation had a negligible and nonsignificant effect on improving physical performance (P > 0·05; Fig. 4 ). According to a fixed-effects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 18·16, df = 60, P = 1·00). The subsequent analysis consisted of subdividing both the athletes and non-athletes into those performing shortand long-duration tests.
Non-athletes subjected to short-duration tests. After pooling the data from eighteen trials, the mean effect size was 0·12 (95 % CI −0·07, 0·31), which indicates that the dietary NO 3 − supplementation had a negligible and non-significant effect on physical performance (P > 0·05; Fig. 5 ). According to a fixed-effects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 4·43, df = 17, P = 0·99).
Athletes subjected to short-duration tests. After pooling the data from seventeen trials, the mean effect size was 0·03 (95 % CI −0·17, 0·23), which indicates that the dietary NO 3 − supplementation had a negligible and non-significant effect on performance (P > 0·05; Fig. 6 ). According to a random-effects Records after reading abstracts and full texts (n 54)
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25 (14 ♂ and 11 ♀) (27) analysis, heterogeneity was observed among these studies (I 2 = 0 %; Q = 13·31, df = 16, P = 0·65).
Non-athletes subjected to long-duration tests. After pooling the data from twenty-five trials, the mean effect size was 0·33 (95 % CI 0·15, 0·51), which indicates that the dietary NO 3 − supplementation had a small and significant beneficial effect on physical performance (P < 0·05; Fig. 7 ). According to a fixedeffects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 8·01, df = 24, P = 0·99).
Athletes subjected to long-duration tests. After pooling the data from forty-four trials, the mean effect size was 0·05 (95 % CI −0·07, 0·17), which indicates that the dietary NO 3 − supplementation had a negligible and non-significant effect on physical performance (P > 0·05; Fig. 8 ). According to a fixed-effects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 4·82, df = 43, P = 1·00). The subsequent analysis consisted of subdividing the non-athletes that performed longduration tests according to the test protocol used.
Non-athletes subjected to long-duration, open-ended tests.
After pooling the data from fourteen trials, the mean effect size was 0·47 (95 % CI 0·23, 0·71), which indicates that the dietary NO 3 − supplementation had a small and significant beneficial effect on physical performance (P < 0·05; Fig. 9 ). According to a fixed-effects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 3·77, df = 13, P = 0·99).
Non-athletes subjected to long-duration time trials. After pooling the data from four trials, the mean effect size was 0·12 (95 % CI −0·37, 0·61), which indicates that the dietary NO 3 − supplementation had a negligible and non-significant effect on physical performance (P > 0·05; Fig. 10 ). According to a fixedeffects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 0·16, df = 3, P = 0·98).
Non-athletes subjected to long-duration, graded-exercise tests. After pooling the data from five trials, the mean effect size was 0·20 (95 % CI −0·18, 0·59), which indicates that the dietary NO 3 − supplementation had a small but non-significant effect on 
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Thompson et al. (53) Thompson et al. (54) -0 . physical performance (P > 0·05; Fig. 11 ). According to a fixedeffects analysis, no heterogeneity was observed among these studies (I 2 = 0 %; Q = 1·38, df = 4, P = 0·84).
Cyclists. Most tested athletes were cyclists; therefore, this subgroup was subjected to a special analysis in which they were evaluated alone without the inclusion of athletes engaged in other sports. After pooling the data from thirty-seven trials, the effect size mean was 0·04 (95 % CI −0·09, 0·17), which indicates that the dietary NO 3 − supplementation had a negligible and non-significant effect on physical performance (P > 0·05; Fig. 12 ). According to a fixed-effects analysis, heterogeneity was observed among these studies (I 2 = 0 %; Q = 4·90, df = 36, P = 1·00).
Analysis of the relationship between the performance level and the ergogenic response to the NO 3 − supplementation
By analysing the percentage of trials reporting increased performance in individuals classified into different PL, we observed numerous trials, that is, 50 and 56·5 %, showing increased performance in individuals with PL1 and PL2, respectively. In contrast, approximately 37 % of the trials involving individuals with PL3 showed an increased performance following the NO 3 − supplementation, whereas in trials involving individuals with PL4 and PL5 no improvement in performance was observed following the NO 3 − supplementation (Fig. 13) . The χ 2 test showed a different distribution among the PL (P = 0·002). 
Association between supplementation features and changes in physical performance
Pearson's correlation analyses were performed to verify the association between these variables, including the association between changes in physical performance and the dose of NO 3 − (non-athletes: r 0·351, P > 0·05; athletes: r 0·099, P > 0·05), the number of days of supplementation (non-athletes: r 0·166, P > 0·05; athletes: r 0·114, P > 0·05) and the total amount ingested (dose multiplied by days under supplementation) (non-athletes: r 0·112, P > 0·05; athletes: r 0·088, P > 0·05). No significant correlations were observed between the supplementation features evaluated and changes in physical performance. Thompson et al. (53) Christensen et al. (2) (42) Kokkinoplitis and Chester (47) Fulford et al. (3) (45) Corry et al. (44) Kelly et al. (4) (46) Mosher et al. 
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Publication bias
Publication bias was assessed by a visual inspection of the funnel plot for all subgroups analysed: non-athletes (online Supplementary Fig. S2(a) ), athletes (online Supplementary Fig. S1(a) ), non-athletes subjected to short-duration tests (online Supplementary Fig. S2(b) ), athletes subjected to short-duration tests (online Supplementary Fig. S1(b) ), non-athletes subjected to long-duration tests (online Supplementary Fig. S2(c) ), athletes subjected to long-duration tests (online Supplementary Fig. S1 (c)), non-athletes subjected to long-duration, open-ended tests (online Supplementary Fig. S3(a) ), non-athletes subjected to long-duration time trials (online Supplementary Fig. S3(b) ) and non-athletes subjected to long-duration, graded-exercise tests (online Supplementary Fig. S3(c) ). These analyses revealed minor asymmetrical inverted distributions that were prominent in all plots, suggesting the presence of a small publication bias.
Risk of bias
The risk of bias was assessed in fifty-four studies (twenty-six and twenty-eight conducted with non-athletes and athletes, respectively) in the systematic review. One study (71) was subjected to two independent evaluations because it presented independent experimental trials. Out of fifty-five evaluations, forty-eight did not present any major risk of bias. Approximately 13 % (non-athletes, two studies; athletes, five studies) of the studies did not blind the participants or researchers. In general, the studies evaluated in the present systematic review showed consistent control of the risk of bias and were deemed to be good-quality studies (online Supplementary Tables S3 and S4) .
Discussion
The present systematic review and meta-analysis demonstrated that the level of physical fitness is a determining factor in the performance-enhancing effects associated with NO 3 − supplementation. Although athletes are usually less prone to benefit from NO 3 − supplementation, non-athletes can experience small but significant advantages in their physical performance, particularly in performance evaluations using long-duration, openended tests. Interestingly, this effect is not observed using time trials, which is the most ecologically valid exercise protocol (77) . These findings regarding the beneficial effects induced by NO 3 − supplementation in non-athletes are supported by the analysis in which the participants were subdivided according to their PL, and those classified at the lower levels (less conditioned) showed more improvements. This information is very important for exercise practitioners and athletes and provides support in decisions regarding whether to use this potential ergogenic aid to improve physical performance and health.
In the present meta-analysis, we observed that individuals with higher fitness levels benefit less from NO 3 − supplementation (Fig. 13) . Consistently, the effect size of NO 3 − supplementationmediated changes on performance in athletes was mostly irrelevant (Fig. 4) . In contrast, non-athletes can benefit from NO 3 − supplementation (Fig. 3) . This was the first study to systematically show the importance of characterising the fitness levels of Murphy et al. (49) Porcelli et al. (3) (51) Aucouturier et al.
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Lansley et al. Several mechanisms may act collectively to improve performance following NO 3 − supplementation in non-athletes, including beneficial effects of an increased NO bioavailability in the skeletal muscles, blood vessels and even in the brain (Fig. 14) . In contrast, the mechanisms underlying the limited ergogenic effects of NO 3 − supplementation in high-performance athletes have not been well elucidated. The ergogenic effects of NO 3 − supplementation are related to enhanced NO bioavailability, and athletes probably already have optimal levels of NO (51) . Highly trained subjects are likely to have high NOS activity (83) , which might render the NO 3
-NO pathway less important for NO production. Therefore, the resulting increase in NO bioavailability due to supplementation does not appear to be relevant in athletes. In addition to these factors, Porcelli et al. (51) suggested that high-performance athletes have a high daily energy expenditure and possibly an enriched diet. Therefore, a diet consisting of a higher intake of NO 3 − in these subjects should be considered. Furthermore, recent evidence that NO 3 − supplementation may preferentially alter contractile function in type II fibres (79) suggests that endurance athletes, who typically have a low proportion of such fibres in their musculature (84) , might experience a blunted physiological response to NO 3 − supplementation.
The effects of NO 3 − supplementation on exercise performance in non-athletes appear to be more robust in evaluations using longduration, open-ended tests rather than time trials. Time-trial tests are the most ecologically valid options to assess performance (6, 85) . Compared with time trials, constant-power (open-ended) tests are more influenced by psychological factors, such as boredom and motivation (86, 87) .
In addition, open-ended tests are more efficient in measuring endurance capacity rather than exercise performance, which is best measured by time-trial protocols (6, 88) . (46) Lansley et al. (23) Aucouturier et al. (1) (38) Aucouturier et al. (2) (38) Nyakayiru et al. (50) Wylie et al. (1) (17) Wylie et al. (3) (17) Wylie et al. (2) (17) Overall (I 2 = 0 . 0 %, P = 0 . 993) 
Vasconcellos et al. (55) Wylie et al. (56) Larsen et al. (15) Breese et al. For example, studies using low doses (4-5·5 mmol) showed that NO 3 − supplementation had either no effects (17, 19, 38, 51) or positive effects (16, 51, 53, 56) on exercise performance. Finally, studies using high doses (>10 mmol) also showed that NO 3 − supplementation had no effects (43, 45, 52) or positive effects (17, 43) on exercise performance.
Despite the high variability in the experimental protocols used in the studies analysed in the present review, the analysed subgroups did not include heterogeneous samples. Therefore, the data homogeneity, the quality of the studies assessed by the risk of bias and the absence of publication bias in the studies used in this systematic review and meta-analysis are sufficient to draw conclusions.
A major limitation of this review is related to the wide variation in the methods (differences in the dose of NO 3 − , number of days of supplementation, total amount ingested and mode of NO 3 − delivery) used in the analysed studies. This methodological diversity complicates the interpretation of the results and precludes clear conclusions regarding certain features of supplementation, such as those listed above. In addition, most studied individuals were men, and whether a sex-related sensitivity to the enhancing effects of nitrate exists in nonathletes is unclear. Thus, future studies should include women as participants.
Practical applications
The present results may encourage coaches, athletes and exercise practitioners to consider the following: (1) NO 3 − supplementation appears to be more effective in non-athletes than in athletes, particularly in performance evaluations using long-duration, open-ended tests; (2) the ergogenic effects mediated by NO 3 − supplementation do not affect physical performance in athletes, including cyclists, which are the most studied athletic population; and (3) subjects classified at a lower PL (i.e. less conditioned) are more responsive to the effects of NO 3 − supplementation than are subjects classified at a higher PL. Reduces the oxygen cost of exercise (14) •
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Physical performance promotes beneficial effects on performance through effects in skeletal muscles, blood vessels and likely in the brain. To date, no study has provided direct evidence showing that NO 3 − supplementation increases brain NO levels (this is the reason why a dashed line is connecting NO to the brain in the schematic). In the skeletal muscles, NO reduces the oxygen cost of exercise (14) , improves mitochondrial efficiency (78) and Ca 2 + handling (79) and increases local blood flow (80) . In the blood vessels, NO increases cutaneous heat loss (81) and reduces blood pressure (82) . Experiments conducted in rats showed that NO in the brain reduces the oxygen cost of exercise (10) , attenuates exercise-induced hyperthermia (11, 13) and increases cutaneous heat loss (13) . Collectively, these physiological responses induced by NO 3 − supplementation improve performance in the conditions mentioned above.
Conclusion
The present systematic review and meta-analysis indicates that dietary NO 3 − supplementation improves physical performance in non-athletes, particularly in performance evaluations using long-duration, open-ended tests. In contrast, dietary NO 3 − supplementation does not appear to benefit the performance of athletes.
